Statistics for Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience
Total visits
| views | |
|---|---|
| Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:3781b144-580b-4aa8-b745-0f37a2d02ad3 | 24 |
| java.util.UUID:5e9f8004-bcc5-4598-a7a2-2b1c7b60a998 | 9 |
| Ekhlaspour2024Safety-CCBY.pdf | 7 |
| java.util.UUID:3f4e66d9-8b41-4721-b58b-87a42d9e6618 | 2 |